Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Nature Biomedical Engineering
|
December 14, 2023
Restoration of sensory feedback from the foot and reduction of phantom limb pain via closed-loop spinal cord stimulation
Ameya C Nanivadekar, Rohit Bose, Bailey A Petersen, et al.
Urologic Oncology
|
November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers
Daniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Nature Biomedical Engineering
|
December 28, 2023
Publisher Correction: Restoration of sensory feedback from the foot and reduction of phantom limb pain via closed-loop spinal cord stimulation
Ameya C Nanivadekar, Rohit Bose, Bailey A Petersen, et al.
JCO Precision Oncology
|
August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
Koichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Frontiers in Oncology
|
April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancer
Tanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursors
Ruhollah Moussavi-Baygi, Matthew J Ryan, Woogwang Sim, et al.
Clinical Genitourinary Cancer
|
June 14, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
Tanya Jindal, Li Zhang, Prianka Deshmukh, et al.
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Nature Biomedical Engineering
|
December 14, 2023
Restoration of sensory feedback from the foot and reduction of phantom limb pain via closed-loop spinal cord stimulation
Ameya C Nanivadekar, Rohit Bose, Bailey A Petersen, et al.
Urologic Oncology
|
November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers
Daniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Nature Biomedical Engineering
|
December 28, 2023
Publisher Correction: Restoration of sensory feedback from the foot and reduction of phantom limb pain via closed-loop spinal cord stimulation
Ameya C Nanivadekar, Rohit Bose, Bailey A Petersen, et al.
JCO Precision Oncology
|
August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
Koichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Frontiers in Oncology
|
April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancer
Tanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursors
Ruhollah Moussavi-Baygi, Matthew J Ryan, Woogwang Sim, et al.
Clinical Genitourinary Cancer
|
June 14, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
Tanya Jindal, Li Zhang, Prianka Deshmukh, et al.
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Page
of 5